Compare Dominion Energy Inc (D) vs Gilead Sciences, Inc. (GILD) Price & Performance

Dominion Energy (D) trades at $61.69, up 0.25% with a bearish technical signal despite recent earnings beats. The company shows strong fundamental improvement with revenue growing to $16.51B in 2025 and net income margin expanding to 18.16%. Analyst consensus is mixed with 36% buy ratings but a $71.56 price target suggests 16% upside potential. Recent news highlights the pending merger with NextEra Energy and ongoing infrastructure investments.

Dominion Energy presents a compelling value opportunity with reasonable valuation multiples (P/E 21.37, P/S 2.96) and consistent earnings outperformance. However, the stock faces headwinds from high debt levels (debt-to-asset ratio 43.49%) and regulatory uncertainty surrounding the proposed merger. The dividend yield of approximately 4.3% provides income support while investors await merger resolution and continued operational execution.

Gilead Sciences (GILD) trades at $150.72, up 2.64% with a bullish technical signal and strong analyst support (65.5% buy ratings). Recent quarterly earnings have consistently beaten expectations, though Q2 2026 showed a significant loss. The company maintains robust operating cash flow ($10.02B in 2025) and is expanding HIV prevention access through new partnerships, positioning for growth despite a negative net income margin of -10.64%.

Outlook is cautiously optimistic with a consensus price target of $151.57, slightly above current levels. Key opportunities include pipeline advances in oncology and HIV treatments, while risks involve profitability volatility, high debt levels, and competitive pressures. The stock's valuation metrics suggest moderate pricing relative to earnings but elevated on sales and book value.